BioSpace News Archive

Immerse Cambridge unveiled as an open, collaborative environment designed to accelerate cutting-edge scientific innovations

Rethinkopioidaddiction.com encourages people to rethink their perceptions of addiction, recovery, and treatment

Flinders University in partnership with Nanit, developers of the leading smart baby monitor and sleep tracker, will present the findings of two collaborative research studies on infant sleep at the 25th Congress of the European Sleep Research Society (ESRS 2020), held online this year from September 22 - 24.

Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the Company’s support services program, Sunovion Answers, has been named as a J.D. Power 2020 Certified Customer Service Pro

Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it entered into a collaborative research agreement with a large pharmaceutical company to evaluate the new AIDD Module in the recently launched version of ADMET Predictor®.

Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,779,874 covering Viveve’s unique method of treatment to address stress urinary incontinence (SUI) in women

Odyssey Investment Partners (“Odyssey”) announced today that it has entered into an agreement to acquire ProPharma Group (or the “Company”) from Linden Capital Partners. Financial terms of the transaction were not disclosed. Founded in 2001, ProPharma Group is a leading provider of regulatory and compliance services to pharmaceutica

Clarius Mobile Health today announces the release of the NEW Clarius L20 HD. In keeping with its mission to deliver accurate, easy-to-use and affordable handheld ultrasound scanners that are suitable for every medical practitioner, this latest innovation features ultra-high definition medical imaging for superficial applications.

Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it has entered into an extensive research collaboration with Public Health England (PHE), an executive agency of the UK’s Department for Health and Social Care (DHSC). As part of this, PHE has launched the ‘Evaluating Detection of SARS-CoV-2 antibodies using home test kits’ study (EDSAB-HOME

PDI, a global leader in infection prevention product and service solutions, today announced the appointment of Michael Yang, Ph.D., as Senior Vice President of Research and Development (R&D).